We are doing this study to learn more about how effective, safe and tolerable an experimental drug called balcinrenone is when used in combination with dapagliflozin for treating patients with heart failure and impaired kidney function and also to better understand the studied disease and associated health problems.
This study is being done to learn more about maridebart cafraglutide (MariTide [formerly AMG 133]) in people with heart failure (HF) and obesity in addition to their routine medical care.
The vaccine made in chicken cells has been tested in many studies and approved in several countries. BN wants to change to making the vaccine in quail cells. This process is easier. It would allow BN to produce many more doses of vaccines in another outbreak.
We want to learn if MVA‑BN that is made in quail cells is as safe as when it is made in chicken cells. We also want to know if MVA‑BN made in quail cells causes a similar immune response.
This study will evaluate the safety, tolerability, and immunogenicity of VAX-31 and the immunogenicity of SIIV when concomitantly and non-concomitantly administered to adults ≥50 years of age.
We are doing this study to learn more about an experimental drug called AZD1613, and also to better understand ADPKD and associated health problems.
We are doing this first-in-human study to learn more about the experimental vaccines AZD4117 and AZD5315 in how they work, how well-tolerated they are, and to better understand if they may protect people from strains of influenza found in birds (H5N1 and H7N9 subtypes of influenza A virus) that may have the potential to cause a pandemic.
In this study, we will test a new influenza (flu) vaccine called the “Flu seasonal mRNA vaccine”. The investigational vaccine is designed to work against the influenza virus. This study is being done to test whether the new study vaccine is safe and how the human body reacts to it.
The purpose of this research study is to test an experimental drug called ORMD-0801, an orally administered formulation of insulin.
We are doing this study to learn more about treatments that could reduce the risk of developing heart failure, reduce the risk of death from cardiovascular causes and also to better understand the studied disease and associated health problems.
